Plexathron^®

Plexathron collagen-containing implant for intra-articular and peri-articular injection 100 mcg/2 ml

- collagen: 100 mcg
- calcium phosphate [Ca 3 (PO 4) 2]: 1 mcg
- sodium chloride [NaCl]: 18 mg
- water for injection [H 2 O]: up to a volume of 2 ml
Specifications: pH 5.2 - 7.0
viscosity 1.50 - 2.30 mPas
osmolality 285-315 mOsm/kg

Plexathron® is a collagen-containing implant for intra-articular
and peri-articular injection, which contributes to an increase in range of motions
by slowing down the degradation of cartilage tissue of the articular surfaces
and repairing damage resulting from:
- aging
- posture disorders
- associated chronic diseases
- bruises and injuries
- toxic lesions of cartilaginous tissue
Plexathron® has the following therapeutic functions:
1. Barrier effect
2. Lubricating effect
3. Mechanical support during other medical treatment

Therapeutic indications
The medical device is used for the following purposes:
- Increased range of motion in the hip joint
- Increasing the elasticity of muscle tissue in the lumbosacral region
- Strengthening of the periarticular muscle tissue
- Local relief of pain, pain during movement, as well as pain caused by posture disorder

During treatment, careful monitoring of the condition of patients taking anticoagulants, or diagnosed with vascular fragility or bleeding disorders, is necessary.

Side effects
Cases of hypersensitivity to the composition of PLEXATHRON were not observed. However, in patients with hypersensitivity to the components, it is necessary to perform a skin-allergic test in the form of a subcutaneous injection into the arm with an assessment of the result after 1 hour.

With pain in the hip joint, it is necessary to conduct a differential diagnosis to identify pain caused by primary and metastatic oncology, referred pain caused by neuralgia of the lumbar spine, inguinal hernia.

Slight redness at the injection site may be due to the mechanical impact of the needle or a skin reaction. When administered, there may be signs of burning/pain at the injection site, which usually disappear spontaneously within 5-10 minutes after the procedure.

Before and after the injection, the skin should be treated with an antiseptic. Pyogenic bacteria can lead to the formation of an abscess at the injection site.

Peri-articular or intra-articular, 1 injection weekly for 10 consecutive weeks.
The treatment regimen is selected individually.

Avoid exposure to sunlight. Do not freeze. The product should be transported under the same conditions as the storage conditions.

At temperature from 2°C to 30°C.
Do not freeze. Avoid exposure to sunlight.
Keep away from children.
Shelf life: 3 years.

The warranty period corresponds to the expiration date. The shelf-life of the medical device is 3 years.

The manufacturer guarantees the quality of the devices and their compliance with the declared specifications during the entire shelf-life provided that the conditions of use, transportation and storage are observed.

The manufacturer or its authorized representative provides information and recommendations regarding risks, as well as guidelines, methods and techniques for using the device.